Provided by Tiger Trade Technology Pte. Ltd.

RenovoRx Inc

1.77
-0.2250-11.28%
Post-market: 1.780.0100+0.56%19:34 EDT
Volume:1.64M
Turnover:3.00M
Market Cap:79.74M
PE:-5.72
High:1.99
Open:1.97
Low:1.71
Close:2.00
52wk High:2.59
52wk Low:0.7006
Shares:45.05M
Float Shares:39.17M
Volume Ratio:0.63
T/O Rate:4.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3096
EPS(LYR):-0.3161
ROE:-125.23%
ROA:-64.90%
PB:8.88
PE(LYR):-5.60

Loading ...

RenovoRx Q1 Adjusted EPS USD -0.08 VS. Ibes Estimate USD -0.08

THOMSON REUTERS
·
May 15

RENOVORX REITERATES FULL YEAR 2026 REVENUE GUIDANCE OF $3 MLN - $4 MLN\n

THOMSON REUTERS
·
May 15

Press Release: RenovoRx Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter

Dow Jones
·
May 15

RenovoRx Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
May 13

RenovoRx forecasts 2026 revenue of $3 million-$4 million

Reuters
·
May 05

RenovoRx announces annual shareholder meeting

Reuters
·
May 01

Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT) and Protara Therapeutics (TARA)

TIPRANKS
·
Apr 29

RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting

GlobeNewswire
·
Apr 23

RenovoRx files to sell 8.44M shares of common stock for holders

TIPRANKS
·
Apr 17

RenovoRx says TAMP study shows reduced tumor activity in pancreatic cancer patients

Reuters
·
Apr 14

RenovoRx Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 09

RenovoRx secures Japanese patent allowance for targeted drug-delivery

TIPRANKS
·
Apr 08

RenovoRx wins Japan patent allowance for RenovoCath drug-delivery device

Reuters
·
Apr 08

RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026

GlobeNewswire
·
Apr 02

Analysts Offer Insights on Healthcare Companies: AbSci (ABSI) and RenovoRx (RNXT)

TIPRANKS
·
Apr 01

RenovoRx Q4 EPS $(0.08), Inline, Sales $238.000K Miss $419.750K Estimate

Benzinga Earnings
·
Mar 31

RenovoRx net loss widens to $11 million in FY25; revenue climbs to $1.1 million

Reuters
·
Mar 31

BRIEF-RenovoRx FY Net Income USD -11.168 Million

Reuters
·
Mar 31

RenovoRx FY Basic EPS USD -0.32

THOMSON REUTERS
·
Mar 31

RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Mar 31